Onkologie. 2024:18(2):145-148 | DOI: 10.36290/xon.2024.027

Atypical intradermal smooth muscle tumor (cutaneous leiomyosarcoma): a case report

Vladimír Bartoš
Martinské bioptické centrum, s. r. o., Martin

Introduction: Atypical intradermal smooth muscle tumor, also called cutaneous leiomyosarcoma, represents a very rare oncodermatological entity. Due to indolent clinical behaviour it is classified as a tumor of uncertain malignant potential.

Case report: A 63year old man presented with a papular skin tumor arising on the extensor size of the upper part of his left arm. The patient claimed that the lesion had been growing for several years. The tumor was completely removed by surgical excision. Histology revealed an intradermal nodule composed of a solid neoplastic smooth muscle population that exhibits focal nuclear atypia, slightly increased proliferative activity and sporadic mitoses. The diagnosis of atypical intradermal smooth muscle tumor was established. The patient was subsequently referred to oncodispensary care and followed up clinically.

Conclusion: Atypical intradermal smooth muscle tumor/cutaneous leiomyosarcoma is a neoplasm with very favourable prognosis, whose complete surgical removal is curative. An increased risk of local recurrence occurs when the subcutis is involved. However, it is necessary to distinguish it from subcutaneous leiomyosarcoma, which represents an etiologically different and prognostically much more serious oncolo­gical disease.

Keywords: atypical intradermal smooth muscle tumor, leiomyosarcoma, pilar leio­myoma.

Accepted: April 19, 2024; Published: May 3, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V. Atypical intradermal smooth muscle tumor (cutaneous leiomyosarcoma): a case report. Onkologie. 2024;18(2):145-148. doi: 10.36290/xon.2024.027.
Download citation

References

  1. Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours. 4th Edition, IARC:Lyon;2018:p.328-330.
  2. Kraft S, Fletcher CDM. Atypical intradermal smooth muscle neoplasms: Clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma". Am J Surg Pathol. 2011;35(4):599-607. Go to original source... Go to PubMed...
  3. Helbig D, Dippel E, Erdmann M, et al. S1-guideline cutaneous and subcutaneous leiomyosarcoma. J Dtsch Dermatol Ges. 2023;21(5):555-563. Go to original source... Go to PubMed...
  4. Soares Queirós C, Filipe P, Soares de Almeida L. Cutaneous leiomyosarcoma: a 20-year retrospective study and review of the literature. An Bras Dermatol. 2021;96(3):278-283. Go to original source... Go to PubMed...
  5. Strouhalová I, Drlík L, Pock L. Kožní leiomyosarkom - popis případu. Čes-slov Derm. 2018;93(1):17-19.
  6. Winchester DS, Hocker TL, Brewer JD, et al. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes. J Am Acad Dermatol. 2014;71(5):919-925. Go to original source... Go to PubMed...
  7. Hall BJ, Hrossmann AH, Webber NP, et al. Atypical intradrmal smooth muscle neoplasms (formerly cutaneous leiomyosarcomas): Case series, immunohistochemical profile and review of the literature. Appl Immunohistochem Mol Morphol. 2013;21(2):132-138. Go to original source... Go to PubMed...
  8. Wong GN, Webb A, Gyorki D, et al. Cutaneous leiomyosarcoma: dermal and subcutaneous. Australas J Dermatol. 2020;61(3):243-249. Go to original source... Go to PubMed...
  9. Massi D, Franchi A, Alos L, et al. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases. Histopathology. 2010;56(2):251-262. Go to original source... Go to PubMed...
  10. Aneiros-Fernandez J, Antonio Retamero J, Husein-Elahmed H, et al. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors. Eur J Dermatol. 2016;26(1):9-12. Go to original source... Go to PubMed...
  11. Rodríguez-Lomba E, Molina-López I, Parra-Blanco V, et al. Clinical and histopathologic findings of cutaneous leiomyosarcoma: Correlation with prognosis in 12 patients. Actas Dermosifiliogr. 2018;109:140-147. Go to original source... Go to PubMed...
  12. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. 5th Edition. Lyon: IARC. 2020;3:195-197.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.